Question special

Clearly one of the key findings in this study was the additional impact of genetic testing in unexplained cases of SCD. Detection of a mutation likely to be causative has downstream effects for family members. Given the variability on health care systems across the globe, the variability in costs of genetic testing and differing possible strategies for approaching genetic testing, how do we move towards clinical use of this approach more broadly?